SERPINE1 and type 2 diabetes mellitus: Lower levels of serum lipoprotein (a) [Lp(a)] and Plasminogen activator inhibitor-1 (PAI-1) can be achieved in controlled and uncomplicated type 2 diabetes mellitus.